The adeno-associated virus major regulatory protein Rep78-c-Jun-DNA motif complex modulates AP-1 activity

Virology

Volumn 314, Issue 1, 2003, Pages 423-431

  Prasad, C Krishna ^a   Meyers, Craig ^b   Zhan, De Jin ^a   You, Hong ^a   Chiriva Internati, Maurizio ^c   Mehta, Jawahar L ^a   Liu, Yong ^a   Hermonat, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Adeno associated virus; c Jun; Protein DNA binding; Protein protein binding; Rep78; Transcription

Indexed keywords

AMINO ACID; CHLORAMPHENICOL ACETYLTRANSFERASE; COMPLEMENTARY DNA; HELICASE; PROTEIN ANTIBODY; PROTEIN C JUN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; VIRUS DNA;

ADENO ASSOCIATED VIRUS; ARTICLE; DNA BINDING MOTIF; DOWN REGULATION; ENZYMATIC ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE MAPPING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; WART VIRUS; WESTERN BLOTTING; YEAST;

ADENO-ASSOCIATED VIRUS; FELIS CATUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0141792095     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00439-2     Document Type: Article

References (51)

1. Angel P., Hattori K., Smeal T., Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP1. Cell. 55:1988;875-885.
2. Angel P., Szabowski A., Schorpp-Kistner M.S. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene. 20:2001;2413-2423.
3. Antinore M.J., Birrer M.J., Patel D., Nader L., McCance D.J. The human pailloma virus type 16 E7 gene product interacts with and transactivates the AP1 family of transcription factors. EMBO J. 15:1996;1950-1960.
4. Bakiri L., Lallemand D., Bossy-wetzel E., Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation a role in the control of cyclin D1 expression . EMBO J. 19:2000;2056-2068.
5. Batchu R.B., Miles D.A., Rechtin T.M., Drake R.R., Hermonat P.L. Cloning, expression and purification of full length Rep78 of adeno-associated virus as a fusion protein with maltose binding protein in Escherichia coli. Biochem. Biophys. Res. Commun. 208:1995;714-720.
6. Batchu R.B., Shammas M.A., Wang J.Y., Munshi N.C. Interaction of adeno-associated virus Rep78 with p53 implications in growth inhibition . Cancer Res. 59:1999;3592-3595.
7. Batchu R.B., Shammas M.A., Wang J.Y., Munshi N.C. Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78. J. Biol. Chem. 276:2001;24315-24322.
8. Chen S.L., Tsao L.T., Tsao Y.P. Antisense oligodeoxynucleotides to c-Jun inhibits proliferation of transformed NIH 3T3 cells induced by E5a of HPV-11. Cancer Lett. 85:1994;119-123.
9. Coker A.L., Russell R.B., Bond S.M., Pirisi L., Liu Y., Mane M., Kokorina N., Gerasimova T., Hermonat P.L. Adeno-associated virus is associated with a lower risk of high grade cervical neoplasia. Exp. Mol. Pathol. 70:2001;83-89.
10. Cripe T.P., Alderborn A., Anderson R.D., Parkkinen S., Bergman P., Haugen T.H., Pettersson U., Turek L.P. Transcriptional activation of the human papillomavirus-16 p97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1 responsive modules. New Biologist. 2:1990;450-463.
11. de la Maza L.M., Carter B.J. Inhibition of adenovirus oncogenicity by adeno-associated virus DNA. J. Natl. Cancer Inst. 67:1981;1323-1326.
12. Fogel S., Riou G. The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms. Virology. 244:1998;97-107.
13. Georg-Fries B., Biederlack S., Wolf J., zur Hausen H. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virol. 134:1984;64-71.
14. Halazonetis T.D., Georgopoulos K., Greenberg M.E., Leder P. C-Jun dimerizes with itself and with c-fos, forming complexes of different binding affinities. Cell. 55:1988;917-924.
15. Hermonat P.L. The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology. 172:1989;253-261.
16. Hermonat P.L. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res. 51:1991;3373-3377.
17. Hermonat P.L. Adeno-associated virus inhibits human papilloma virus type 16; a viral interaction implicated in cervical cancer. Cancer Res. 54:1994;2278a-2281.
18. Hermonat P.L. Down regulation of the human c-fos and c-myc proto-oncogene promotors by adeno-associated virus Rep78. Cancer Lett. 81:1994;129-136.
19. Hermonat P.L., Labow M.A., Wright R., Berns K.I., Muzyczka N. Genetics of adeno-associated virus isolation and characterization of adeno-associated virus type 2 mutants . J. Virol. 51:1984;329-339.
20. Hermonat P.L., Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector transduction of neomycin resistance into mammalian tissue culture cells . Proc. Natl. Acad. Sci. USA. 81:1984;6466-6470.
21. Hermonat P.L., Plott R.T., Santin A.D., Parham G.P., Flick J.T. The adeno-associated virus Rep78 gene inhibits oncogenic transformation of primary keratinocytes by a human papillomavirus type 16-ras chimeric. Gynecol. Oncol. 66:1997;487-494.
22. Hermonat P.L., Santin A.D., Batchu R.B. The adeno-associated virus Rep78 major regulatory/transformation suppressor protein binds cellular Sp1 in vitro and evidence of a biological effect. Cancer Res. 56:1996;5299-53304.
23. Hermonat P.L., Santin A.D., Batchu R.B., Zhan D.-J. The adeno-associated virus Rep78 major regulatory protein binds the cellular TATA binding protein in vitro and in vivo. Virology. 245:1998;120-127.
24. Hermonat P.L., Santin A.D., Zhan D. Binding of the human papilloma virus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects. J. Hum. Virol. 3:2000;113-124.
25. Horer M., Weger S., Butz K., Hoppe-Seyler F., Geisen C., Kleinschmidt J.A. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J. Virol. 69:1995;5485-5496.
26. Hubert W.G., Kanaya T., Laimins L.A. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5′ of the minimal origin. J. Virol. 73:1999;1835-1845.
27. Kyo S., Klumpp D.J., Inoue M., Kanaya T., Laimins L.A. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J. Gen. Virol. 78:1997;401-411.
28. Labow M.A., Hermonat P.L., Berns K.I. Positive and negative autoregulation of the adeno-associated virus type 2 genome. J. Virol. 60:1986;251-258.
29. Mayor H.D., Drake S., Stahmann J., Mumford D.M. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am. J. Obstet. Gyn. 126:1976;100-104.
30. Meyers C., Alam S., Manc M., Hermonat P.L. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue. Virology. 287:2001;30-39.
31. Meyers C., Frattini M.G., Hudson J.B., Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science. 257:1992;971-973.
32. Meyer C., Mane M., Kokorina N., Alam S., Hermonat P.L. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology. 272:2000;338-346.
33. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., Zacny V.L. Biological activities and molecular targets of the human papilloma virus E7 oncoprotein. Oncogene. 26:2001;7888-7898.
34. Myers M.W., Laughlin C.A., Jay F.T., Carter B.J. Adenovirus helper functions for growth of adeno-associated virus effect of temperature-sensitive mutations in adenovirus early gene region 2 . J. Virol. 35:1980;65-75.
35. Ni T.H., Zhou X., McCarty D.M., Zolotukhin I., Muzyczka N. In vitro replication of adeno-associated virus DNA. J. Virol. 68:1994;1128-1138.
36. Nurnberg W., Artuc M., Vorbrueggen G., Kalkbrenner F., Moelling K., Czarnetzki B.M., Schadendorf D. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. Br. J. Cancer. 71:1995;1018-1024.
37. Ogston P., Raj K., Beard P. Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes is agumented by the HPV-16 E2 protein. J. Virol. 74:2000;3494-3504.
38. Ostrove J.M., Duckworth D.H., Berns K.I. Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology. 113:1981;521-533.
39. Saudan P., Vlach J., Beard P. Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J. 19:2000;4351-4361.
40. Smith J., Herrero R., Erles K., Grimm D., Munoz N., Bosch F.X., Tafur L., Shah K.V., Schlehofer J.R. Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Columbia. Int. J. Cancer. 94:2001;520-526.
41. Soto U., Das B.C., Lengert M., Finzer P., zur Hausen H., Rosl F. Conversion of HPV18 non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene. 18:1999;3187-3198.
42. Thomas M., Pim D., Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 18:1999;7690-7700.
43. Tratschin J.D., Miller I.L., Carter B.J. Genetic analysis of adeno-associated virus properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function . J. Virol. 51:1984;611-619.
44. Tratschin J.D., Tal J., Carter B.J. Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol. Cell Biol. 6:1986;2884-2894.
45. Walz C., Deprez A., Dupressoir T., Durst M., Rabreau M., Schlehofer J.R. Interaction of human papilloma virus type 16 and adeno associated virus type 2 co-infecting human cervical epithelium. J. Gen. Virol. 78:1997;1441-1452.
46. Walz C.M., Correa-Ochoa M.M., Muller M., Schlehofer J.R. Adeno-associated virus type 2-induced inhibition of the human papilloma virus type 18 promoter in transgenic mice. J. Virol. 293:2002;172-181.
47. Weger S., Wendland M., Kleinschmidt J.A., Heilbronn R. The adeno-associated virus type 2 regulatory proteins Rep78 and rep68 interact with the transcriptional coactivator PC4. J. Virol. 73:1999;260-269.
48. Weindler F.W., Heilbronn R. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J. Virol. 65:1991;2476-2483.
49. Weitzman M.D., Kyostio S.R., Kotin R.M., Owens R.A. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA. 91:1994;5808-5812.
50. Young S.M. Jr., McCarty D.M., Degtyareva N., Samulski R.J. Roles of adeno-associated virus rep protein and human chromosome 19 site-specific recombination. J. Virol. 74:2000;3953-3966.
51. Zhan D.-J., Santin A.D., Liu Y., Parham G.P., Li C., Meyers C., Hermonat P.L. Binding of the human pailloma virus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition. J. Biol. Chem. 274:1999;31619-31624.